Latest Advances

  • Condition: Axial Spondyloarthritis
  • Journal: PloS one
  • Treatment Used: Tumor Necrosis Factor A Inhibitors (TNFi)
  • Number of Patients: 16
  • Published —
This study evaluated the impact of tumor necrosis factor a inhibitors (medicines that suppress the body's natural response to tumor necrosis factor, a protein produced by white blood cells that is involved in early inflammatory events; TNFi) in patients with axial spondyloarthritis (chronic, autoinflammatory disease predominantly affecting the axial skeleton, which is the central axis of the body and includes the bones of the skull, ossicles of the middle ear, hyoid bone of the throat, vertebral column, and the ribcage).
  • Condition: Axial Spondyloarthritis
  • Journal: RMD open
  • Treatment Used: Secukinumab
  • Number of Patients: 1860
  • Published —
This study explored the effectiveness of 6-month and 12-month secukinumab in patients with axial spondyloarthritis (spinal degeneration; axSpA).
  • Condition: Axial Spondyloarthritis
  • Journal: Arthritis research & therapy
  • Treatment Used: TNF Inhibitors
  • Number of Patients: 193
  • Published —
This study investigated if switching TNF inhibitors after a primary or secondary failure provides good clinical outcomes in patients with axial spondyloarthritis.
  • Condition: Axial Spondyloarthritis
  • Journal: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group
  • Treatment Used: Serial Locally Applied Water-filtered Infrared a Radiation (sl-wIRAR)
  • Number of Patients: 71
  • Published —
In this study, researchers evaluated the outcomes of using serial locally applied water-filtered infrared A radiation (sl-wIRAR) for the treatment of axial spondyloarthritis.
  • Condition: Axial Spondyloarthritis
  • Journal: Annals of the rheumatic diseases
  • Treatment Used: Secukinumab
  • Number of Patients: 390
  • Published —
This study tested the safety and efficacy of using secukinumab to treat patients with axial spondyloarthritis that have already been previously treated with TNF inhibitors.
  • Condition: Axial Spondyloarthritis
  • Journal: RMD open
  • Treatment Used: Certolizumab Pegol
  • Number of Patients: 89
  • Published —
The study researched the impact of certolizumab pegol treatment on the incidence of anterior uveitis flares in patients with axial spondyloarthritis.
  • Condition: Axial Spondyloarthritis
  • Journal: Mediators of inflammation
  • Treatment Used: Secukinumab
  • Number of Patients: 39
  • Published —
This study tested the safety and efficacy of using secukinumab to treat patients with axial spondyloarthritis.
  • Condition: Axial Spondyloarthritis (AxSpA)
  • Journal: Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan
  • Treatment Used: Qushi Xiezhuo Formula (QSXZF)
  • Number of Patients: 62
  • Published —
This study investigated the effect of Qushi Xiezhuo formula (QSXZF) on axial spondyloarthritis (autoinflammatory disease affecting the joints of the spine, chest and pelvis; AxSpA) with a high incidence of monosodium serum urate (MSU) crystal deposition (gout).
  • Condition: Radiographic Progression in Axial Spondyloarthritis
  • Journal: Arthritis & rheumatology (Hoboken, N.J.)
  • Treatment Used: Tumor Necrosis Factor Inhibitors (TNFi), Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Secukinumab
  • Number of Patients: 0
  • Published —
This review of the literature investigated the effect of therapies on radiographic progression in patients with axial spondyloarthritis (spinal arthritis; SpA).
  • Condition: Axial Spondyloarthritis
  • Journal: Journal of autoimmunity
  • Treatment Used: Treat toTarget Strategy
  • Number of Patients: 0
  • Published —
This article discusses a treat to target strategy for axial spondyloarthritis.
  • Condition: Non-Radiographic Axial Spondyloarthritis
  • Journal: Lancet (London, England)
  • Treatment Used: Ixekizumab
  • Number of Patients: 303
  • Published —
In this study, researchers evaluated the safety and effectiveness of ixekizumab for the treatment of non-radiographic axial spondyloarthritis.
  • Condition: Axial Spondyloarthritis
  • Journal: PloS one
  • Treatment Used: Add-On Training Program
  • Number of Patients: 24
  • Published —
This study tested the safety and efficacy of including a training program that incorporates breathing exercises, cold exposure, and meditation to improve clinical parameters in patients with axial spondyloarthritis.
Showing 1-12 of 31